U.K. Biotech Stocks

AstraZeneca

Market Cap: UK£210.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£75.3b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Haleon

Market Cap: UK£33.7b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Hikma Pharmaceuticals

Market Cap: UK£3.4b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

HUTCHMED (China)

Market Cap: UK£1.9b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Oxford Nanopore Technologies

Market Cap: UK£1.5b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

Oxford Biomedica

Market Cap: UK£1.0b

A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.

PureTech Health

Market Cap: UK£320.0m

Engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.

Diaceutics

Market Cap: UK£144.4m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Shield Therapeutics

Market Cap: UK£114.8m

A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.

Bioventix

Market Cap: UK£96.7m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

SkinBioTherapeutics

Market Cap: UK£53.1m

A life science company, engages in research and development, and commercialization of technology that harnesses the microbiome for human health in the United Kingdom, the United States, Europe, and internationally.

hVIVO

Market Cap: UK£40.8m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

Poolbeg Pharma

Market Cap: UK£31.0m

A clinical-stage biopharmaceutical company, focused on acquiring, developing, and commercialising of medicines for unmet medical needs in the United Kingdom.

Arecor Therapeutics

Market Cap: UK£30.8m

A clinical stage biotechnology company, develops innovative medicines that address significant unmet patient needs in the United Kingdom.

Palatin Technologies

Market Cap: US$27.0m

A biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States.

Solvonis Therapeutics

Market Cap: UK£17.4m

A clinical-stage biopharmaceutical company, develops novel medicines for addiction and mental health disorders.

IXICO

Market Cap: UK£10.4m

Provides data analytics services to biopharmaceutical industry in the United States, the United Kingdom, the Netherlands, Denmark, Switzerland, Ireland, Europe, and internationally.

Futura Medical

Market Cap: UK£7.7m

Research, develops, and commercializes pharmaceutical and healthcare products for sexual health.

Proteome Sciences

Market Cap: UK£6.3m

Provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally.

Cardiogeni

Market Cap: UK£6.2m

A clinical stage biotechnology company, develops heart failure medicines.

Theracryf

Market Cap: UK£4.5m

A clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders.

N4 Pharma

Market Cap: UK£4.0m

A specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom.

ValiRx

Market Cap: UK£2.6m

A biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom.

BSF Enterprise

Market Cap: UK£2.6m

Develops and commercializes cutting-edge tissue-engineered solutions.

Roquefort Therapeutics

Market Cap: UK£2.1m

A material biotech company, engages in the development of medicines for the treatment of cancer.

Physiomics

Market Cap: UK£1.4m

Provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland.

Kanabo Group

Market Cap: UK£1.4m

A digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices.